Epimedin A inhibits the PI3K/AKT/NF-κB signalling axis and osteoclast differentiation by negatively regulating TRAF6 expression

Jun Li(Nanjing University of Chinese Medicine), Ting Yang(Nanjing University of Chinese Medicine)

Molecular Medicine

August 16, 2024

10.1186/s10020-024-00893-w

Cited by 16

Related Papers

Vascular Normalization: A New Window Opened for Cancer Therapies

|Frontiers in Oncology|2021|112

Epimedin A inhibits the PI3K/AKT/NF-κB signalling axis and osteoclast differentiation by negatively regulating TRAF6 expression

|Research Square|2024|0